My questions are
1. What is wrong with our society that we have to go outside the United States for better, newer or cheaper treatments for Health and Well being?
A clear example of what is wrong is people like Leon Kass, advisor to George Bush, who has religious and gender biases and does not want advances to change how much death there is or how soon it happens. He even questions the advances in the 20th century extending life expectancy.
2. Why is the FDA approval and the scientific research not adjusted to achieve faster results and approvals ? The system needs to take into account the risks that an individual already faces from ineffective treatments. We should not have delays that do not result in actual increases in safety.
3. We need to focus medical research guided by metrics for results in extending lifespan and improved health. There is too much money going into treatments that are not improving lifespan but which replace a marginal effective but profitable drug for treating some symptom. Too much just flows to institutions that have historically received money but which are not measured by the results that they have delivered.
4. There is also the budget tension between hospices and costs for those who are sick and research to actually cure aging and disease. The bulk of the money for medical research should be focused on impacting aging processes and resistance and recuperation from disease. The allocation should be made at the top level. Budget $X for underlying causes of aging and interventions, C$ for disease cures, Y$ for symptom management and Z$ for hospice care. The X$ amount is far too small and often gets diverted into the other buckets.
Brian Wang is a Futurist Thought Leader and a popular Science blogger with 1 million readers per month. His blog Nextbigfuture.com is ranked #1 Science News Blog. It covers many disruptive technology and trends including Space, Robotics, Artificial Intelligence, Medicine, Anti-aging Biotechnology, and Nanotechnology.
Known for identifying cutting edge technologies, he is currently a Co-Founder of a startup and fundraiser for high potential early-stage companies. He is the Head of Research for Allocations for deep technology investments and an Angel Investor at Space Angels.
A frequent speaker at corporations, he has been a TEDx speaker, a Singularity University speaker and guest at numerous interviews for radio and podcasts. He is open to public speaking and advising engagements.